Comprehensive 2026 guide details DSHEA, 21 CFR Part 111 GMPs, NDI notifications, labeling, and FDA enforcement trends ...
According to the order, products marketed for pain relief and relaxation were confirmed to contain Kratom, a Schedule I controlled substance, with no notice given to the consumer.